李建勇, 钟立业. 单独化疗及缓解后的强化治疗使年轻成人急性淋巴细胞白血病取得良好结果的相关研究[J]. 循证医学, 2011, 11(5): 279-281. DOI: 10.3969/j.issn.1671-5144.2011.05.016
    引用本文: 李建勇, 钟立业. 单独化疗及缓解后的强化治疗使年轻成人急性淋巴细胞白血病取得良好结果的相关研究[J]. 循证医学, 2011, 11(5): 279-281. DOI: 10.3969/j.issn.1671-5144.2011.05.016
    LI Jian-yong, ZHONG Li-ye. Young Adults with Acute Lymphoblastic Leukemia Have An Excellent Outcome with Chemotherapy Alone and Benefit from Intensive Postinduction Treatment: A Report from the Children’s Oncology Group[J]. Journal of Evidence-Based Medicine, 2011, 11(5): 279-281. DOI: 10.3969/j.issn.1671-5144.2011.05.016
    Citation: LI Jian-yong, ZHONG Li-ye. Young Adults with Acute Lymphoblastic Leukemia Have An Excellent Outcome with Chemotherapy Alone and Benefit from Intensive Postinduction Treatment: A Report from the Children’s Oncology Group[J]. Journal of Evidence-Based Medicine, 2011, 11(5): 279-281. DOI: 10.3969/j.issn.1671-5144.2011.05.016

    单独化疗及缓解后的强化治疗使年轻成人急性淋巴细胞白血病取得良好结果的相关研究

    Young Adults with Acute Lymphoblastic Leukemia Have An Excellent Outcome with Chemotherapy Alone and Benefit from Intensive Postinduction Treatment: A Report from the Children’s Oncology Group

    • 摘要: 年龄16~21岁的年轻成人ALL是相对特殊的一种ALL, 儿科及成人血液科医生均可能对其进行诊治, 但< 18岁的患者常由儿科血液病医生诊治, 18~21岁则常在成人血液科诊治。年轻成人ALL的预后显著差于儿童ALL, 除由于白血病细胞本身的生物学特征、患者/医生的依从性及心理社会因素不同外, 不同的治疗方案可能是影响患者预后的最重要原因之一。

       

    /

    返回文章
    返回